Clinical Trials Directory

Trials / Completed

CompletedNCT04689399

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,697 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This project aims to investigate the sensitivity and specificity of the rapid antigen test compared to RT-PCR test performed on samples from the nasopharynx and the anterior nasal cavity and the oropharynx, respectively.

Detailed description

The purpose of the study is to investigate the sensitivity and specificity of correct SARS-CoV-2 test results of nasopharyngeal swabs and swabs swabs from the anterior part of the nose examined by rapid antigen test (Standard Q COVID-19 Ag - test, SD Biosensor INC.) compared with swabs from the oropharynx examined by RT-PCR test among citizens who have booked an appointment for a COVID-19 test in one of Testcenter Denmark's test centers in the Capital Region.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTStandard Q COVID-19 Ag - test, produced by SD Biosensor INC.Alle Danish citizens tested for infection with SARS-CoV-2 by swabs in the oropharynx, and subsequently analysis of the specimens by RT-PCR test at Testcenter Danmark's test centers will be included in the study. Participants will, in addition to the oropharyngeal swab they are already schedule for, be examined by a rapid antigen test.

Timeline

Start date
2020-12-26
Primary completion
2021-03-25
Completion
2021-03-25
First posted
2020-12-30
Last updated
2021-03-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04689399. Inclusion in this directory is not an endorsement.